Tune in to this webcast from a live webinar where leading experts in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) as well as bispecific antibody therapies discuss solutions for overcoming persistent gaps in integrating bispecific antibodies into DLBCL and FL treatment plans. Leveraging key data and insights stemming from provider surveys and recent protocol integration sessions, expert faculty present the latest evidence and guideline recommendations for bispecific antibodies for DLBCL/FL treatment. Additionally, utilizing a bispecific antibody integration protocol developed specifically for this program, faculty walk through this roadmap, providing best practices for prescribing, administering, and managing bispecific antibodies in your setting. Don’t miss this opportunity to enhance your knowledge and harness new approaches to optimize DLBCL/FL care with bispecific antibodies.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 17, 2025
-
Last day to claim creditOct 17, 2026 6 days left
-
Medscape, LLC Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case Based Discussion
-
HealthTree Foundation for Non-Hodgkin Lymphoma +1 Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond
-
CancerNet +1 Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations
-
PRIME Education, Inc. (PRIME®) Accelerating Evidence Into Practice: Latest Guidelines and Clinical Evidence for Bispecific Antibodies in R/R DLBCL and FL
-
PRIME Education, Inc. (PRIME®) Accelerating Evidence Into Practice: Optimizing Bispecific Antibody Administration for R/R DLBCL and FL
-
PRIME Education, Inc. (PRIME®) Step Up for Success: Navigating Bispecific Antibody Care Across Practice Settings in Multiple Myeloma
